Gene_set,Term,Overlap,P-value,Adjusted P-value,Old P-value,Old Adjusted P-value,Odds Ratio,Combined Score,Genes
KEGG_2021_Human,Ribosome,50/158,1.8191747411823893e-33,4.184101904719495e-31,0,0,13.186533487425018,994.0922124698976,RPL5;RPL30;RPL3;RPL34;RPLP1;RPL8;RPL9;RPS15;RPS4X;RPS14;RPL7A;RPS16;RPL18A;RPL36AL;RPL35;RPLP2;RPL38;RPL39;RPS13;RPS12;RPS9;RPL21;RPS7;RPS8;RPL23;RPS6;RPL13A;RPS3A;RPL24;RPL27;RPL29;RPL10;RPL12;RPL11;MRPL20;RPL13;RPL15;RPL18;RPS27A;RPL19;RPL41;RPL35A;RPS26;RPS25;RPS27;RPL27A;FAU;RPS21;RPS24;RPS23
KEGG_2021_Human,Coronavirus disease,54/232,1.412510997668854e-28,1.624387647319182e-26,0,0,8.660805159469945,555.3915705415764,RPL5;RPL30;RPL3;RPL34;RPLP1;PIK3CB;RPL8;RPL9;RPS15;RPS4X;RPS14;RPL7A;RPS16;RPL18A;RPL36AL;RPL35;RPLP2;RPL38;RPL39;RPS13;RPS12;RPS9;RPL21;RPS7;RPS8;RPL23;RPS6;RPL13A;RPS3A;RPL24;RPL27;RPL29;RPL10;RPL12;RPL11;RPL13;RPL15;RPL18;RPS27A;RPL19;RPL41;STAT1;STAT2;MX1;RPL35A;ISG15;RPS26;RPS25;RPS27;RPL27A;FAU;RPS21;RPS24;RPS23
KEGG_2021_Human,Parkinson disease,14/249,0.0689794514883301,0.99999603346069,0,0,1.600024007442307,4.278378791826335,NDUFA6;COX4I1;NDUFA2;NDUFC1;COX7C;COX7A1;PSMA7;PSMB6;TUBB6;KLC3;NDUFS5;UQCRFS1;RPS27A;SLC18A2
KEGG_2021_Human,Oxidative phosphorylation,8/133,0.1094840846906698,0.99999603346069,0,0,1.7143048951048951,3.792001431364619,NDUFA6;COX4I1;NDUFS5;NDUFA2;UQCRFS1;NDUFC1;COX7A1;COX7C
KEGG_2021_Human,Non-alcoholic fatty liver disease,9/155,0.1098392345097866,0.99999603346069,0,0,1.6516921837228042,3.648154442654115,NDUFA6;COX4I1;NDUFS5;NDUFA2;UQCRFS1;NDUFC1;PIK3CB;COX7A1;COX7C
KEGG_2021_Human,Prion disease,14/273,0.1206030923385994,0.99999603346069,0,0,1.4499294781382228,3.066963841523933,NDUFA6;COX4I1;NDUFA2;NDUFC1;PIK3CB;COX7C;COX7A1;PSMA7;GRIN2D;PSMB6;TUBB6;KLC3;NDUFS5;UQCRFS1
KEGG_2021_Human,Allograft rejection,3/38,0.1572153438285804,0.99999603346069,0,0,2.290714285714286,4.238139372150923,IL5;HLA-B;HLA-A
KEGG_2021_Human,Ferroptosis,3/41,0.184104781037738,0.99999603346069,0,0,2.1095394736842104,3.569868641169643,FTH1;CP;FTL
KEGG_2021_Human,Protein export,2/23,0.2013273441856251,0.99999603346069,0,0,2.5435572287167294,4.076872327075623,SRPRA;SEC11C
KEGG_2021_Human,HIF-1 signaling pathway,6/109,0.2021048343141599,0.99999603346069,0,0,1.5577852703416335,2.4908499422663137,LDHC;IFNGR2;RPS6;ELOB;PIK3CB;ENO4
KEGG_2021_Human,Glycolysis / Gluconeogenesis,4/67,0.2233933587259144,0.99999603346069,0,0,1.696712806587633,2.543068990721937,LDHC;ADH4;GAPDHS;ENO4
KEGG_2021_Human,Proteasome,3/46,0.2312241868073302,0.99999603346069,0,0,1.8637596899224809,2.7292291800511728,PSMB6;PSMA7;PSMB9
KEGG_2021_Human,Biosynthesis of unsaturated fatty acids,2/27,0.2552091063560561,0.99999603346069,0,0,2.136144244105409,2.9172724781230235,ACOT2;ACOT1
KEGG_2021_Human,Fatty acid elongation,2/27,0.2552091063560561,0.99999603346069,0,0,2.136144244105409,2.9172724781230235,ACOT2;ACOT1
KEGG_2021_Human,Cysteine and methionine metabolism,3/50,0.2703169548656567,0.99999603346069,0,0,1.7047872340425532,2.230134641229906,LDHC;BHMT;APIP
KEGG_2021_Human,Hematopoietic cell lineage,5/99,0.2877839208755278,0.99999603346069,0,0,1.421131393350323,1.770083606089243,IL5;IL1R1;IL7;CD9;CD24
KEGG_2021_Human,Metabolism of xenobiotics by cytochrome P450,4/76,0.2951917231804721,0.99999603346069,0,0,1.4839282954721065,1.810585764526919,ADH4;GSTP1;AKR1C1;CBR3
KEGG_2021_Human,Autoimmune thyroid disease,3/53,0.3000886765599099,0.99999603346069,0,0,1.60225,1.9285918889867475,IL5;HLA-B;HLA-A
KEGG_2021_Human,Antigen processing and presentation,4/78,0.3115781310908421,0.99999603346069,0,0,1.443671766342142,1.6834730817620829,CTSL;HLA-B;HLA-A;B2M
KEGG_2021_Human,Diabetic cardiomyopathy,9/203,0.3138033598390812,0.99999603346069,0,0,1.2399073031274366,1.437038592796702,NDUFA6;COX4I1;NDUFS5;NDUFA2;UQCRFS1;NDUFC1;PIK3CB;COX7C;COX7A1
KEGG_2021_Human,Huntington disease,13/306,0.3153195769659102,0.99999603346069,0,0,1.186328894870932,1.3692235886717965,NDUFA6;COX4I1;NDUFA2;NDUFC1;ATG14;COX7C;COX7A1;PSMA7;PSMB6;TUBB6;KLC3;NDUFS5;UQCRFS1
KEGG_2021_Human,Pyrimidine metabolism,3/56,0.3300145266245742,0.99999603346069,0,0,1.5113207547169811,1.6754783074305948,PNP;ENTPD3;CMPK2
KEGG_2021_Human,Thermogenesis,10/232,0.3303934578261007,0.99999603346069,0,0,1.203833567087424,1.333210810482476,NDUFA6;COX4I1;NDUFS5;RPS6;NDUFA2;UQCRFS1;NDUFC1;COX7C;COX7A1;COX20
KEGG_2021_Human,Fructose and mannose metabolism,2/33,0.3361322733873912,0.99999603346069,0,0,1.7221600823229386,1.877585935076885,GMPPB;ENOSF1
KEGG_2021_Human,SNARE interactions in vesicular transport,2/33,0.3361322733873912,0.99999603346069,0,0,1.7221600823229386,1.877585935076885,STX16;STX19
KEGG_2021_Human,Alzheimer disease,15/369,0.3579241022053612,0.99999603346069,0,0,1.1325169970315043,1.1635868308134996,NDUFA6;COX4I1;NDUFA2;NDUFC1;PIK3CB;ATG14;COX7C;COX7A1;PSMA7;GRIN2D;PSMB6;TUBB6;KLC3;NDUFS5;UQCRFS1
KEGG_2021_Human,Nicotinate and nicotinamide metabolism,2/35,0.3626153296841757,0.99999603346069,0,0,1.6176186273273652,1.6409328864895785,PNP;NMNAT3
KEGG_2021_Human,JAK-STAT signaling pathway,7/162,0.3700606110091917,0.99999603346069,0,0,1.2061092088664624,1.198979261980433,PIAS3;IL5;IL7;STAT1;IFNGR2;STAT2;PIK3CB
KEGG_2021_Human,Cardiac muscle contraction,4/87,0.3858586119369957,0.99999603346069,0,0,1.2865257972083046,1.225138275689606,COX4I1;UQCRFS1;COX7C;COX7A1
KEGG_2021_Human,PD-L1 expression and PD-1 checkpoint pathway in cancer,4/89,0.4023050994516581,0.99999603346069,0,0,1.2561237012190134,1.1437565580676978,STAT1;IFNGR2;PIK3CB;RASGRP1
KEGG_2021_Human,Inflammatory bowel disease,3/65,0.4189299378802917,0.99999603346069,0,0,1.2913306451612905,1.1235242755343993,IL5;STAT1;IFNGR2
KEGG_2021_Human,Aminoacyl-tRNA biosynthesis,3/66,0.428607386619639,0.99999603346069,0,0,1.2707671957671958,1.0766117104441562,GARS1;PARS2;WARS1
KEGG_2021_Human,Amyotrophic lateral sclerosis,14/364,0.4448194194012084,0.99999603346069,0,0,1.0678138222849085,0.8650219658715846,NDUFA6;COX4I1;NDUFA2;NDUFC1;ATG14;COX7C;COX7A1;PSMA7;GRIN2D;PSMB6;TUBB6;KLC3;NDUFS5;UQCRFS1
KEGG_2021_Human,Epstein-Barr virus infection,8/202,0.4472510293108982,0.99999603346069,0,0,1.1005983707014635,0.8855802508536378,ENTPD3;STAT1;STAT2;HLA-B;ISG15;HLA-A;PIK3CB;B2M
KEGG_2021_Human,Graft-versus-host disease,2/42,0.451622185663787,0.99999603346069,0,0,1.3340499306518725,1.0604487247030616,HLA-B;HLA-A
KEGG_2021_Human,Tryptophan metabolism,2/42,0.451622185663787,0.99999603346069,0,0,1.3340499306518725,1.0604487247030616,KMO;ACMSD
KEGG_2021_Human,Type I diabetes mellitus,2/43,0.4637668974909495,0.99999603346069,0,0,1.3014444707553872,0.9999950904705988,HLA-B;HLA-A
KEGG_2021_Human,Central carbon metabolism in cancer,3/70,0.4666965403331245,0.99999603346069,0,0,1.1946517412935322,0.9104154671043736,LDHC;PIK3CB;SLC16A3
KEGG_2021_Human,Prolactin signaling pathway,3/70,0.4666965403331245,0.99999603346069,0,0,1.1946517412935322,0.9104154671043736,STAT1;IRF1;PIK3CB
KEGG_2021_Human,Fatty acid biosynthesis,1/18,0.4847167791599755,0.99999603346069,0,0,1.5691706045299003,1.1363784746680536,HSD17B8
KEGG_2021_Human,Osteoclast differentiation,5/127,0.4874646611895846,0.99999603346069,0,0,1.0933718434631718,0.7856286502412919,IL1R1;STAT1;IFNGR2;STAT2;PIK3CB
KEGG_2021_Human,Purine metabolism,5/129,0.501249167600333,0.99999603346069,0,0,1.0756244945637523,0.7428821664813314,PNP;ENTPD3;PDE4A;PDE5A;PDE6B
KEGG_2021_Human,Pyruvate metabolism,2/47,0.5107047457187116,0.99999603346069,0,0,1.1855139466789952,0.796622282050337,LDHC;ADH4
KEGG_2021_Human,Necroptosis,6/159,0.515798030260571,0.99999603346069,0,0,1.045970410479394,0.6924742551004188,STAT1;FTH1;H2AC20;IFNGR2;STAT2;FTL
KEGG_2021_Human,Steroid biosynthesis,1/20,0.5213315351221389,0.99999603346069,0,0,1.4038489575739903,0.91442382614197,DHCR24
KEGG_2021_Human,C-type lectin receptor signaling pathway,4/104,0.5214975628747452,0.99999603346069,0,0,1.0668706536856745,0.6945868622612875,STAT1;IRF1;STAT2;PIK3CB
KEGG_2021_Human,Amino sugar and nucleotide sugar metabolism,2/48,0.5220111666055671,0.99999603346069,0,0,1.159681601640234,0.7538699272183371,GMPPB;GNE
KEGG_2021_Human,Cocaine addiction,2/49,0.5331408792688391,0.99999603346069,0,0,1.1349485053265265,0.7138480800815232,SLC18A2;GRIN2D
KEGG_2021_Human,Arginine and proline metabolism,2/50,0.5440918697707101,0.99999603346069,0,0,1.1112459546925566,0.6763455909594845,ARG2;P4HA3
KEGG_2021_Human,Vibrio cholerae infection,2/50,0.5440918697707101,0.99999603346069,0,0,1.1112459546925566,0.6763455909594845,KDELR3;CFTR
KEGG_2021_Human,Kaposi sarcoma-associated herpesvirus infection,7/193,0.550236588223884,0.99999603346069,0,0,1.0034615846699104,0.5994749075214437,STAT1;STAT2;HLA-B;HLA-A;PIK3CB;ATG14;RPS27A
KEGG_2021_Human,Ribosome biogenesis in eukaryotes,4/108,0.5514035032890198,0.99999603346069,0,0,1.0256231946078955,0.6105416181806722,POP5;EMG1;RPP38;NOP10
KEGG_2021_Human,Ovarian steroidogenesis,2/51,0.5548625000103314,0.99999603346069,0,0,1.0885108551048714,0.6411709302093144,ACOT2;ACOT1
KEGG_2021_Human,Arginine biosynthesis,1/22,0.5553478709105787,0.99999603346069,0,0,1.2700171481334916,0.7469740061438036,ARG2
KEGG_2021_Human,Ubiquitin mediated proteolysis,5/140,0.5741695732477757,0.99999603346069,0,0,0.9874135974414526,0.5478471824585547,PIAS3;ELOB;RPS27A;ANAPC11;RHOBTB2
KEGG_2021_Human,Vitamin digestion and absorption,1/24,0.5869499497420547,0.99999603346069,0,0,1.1594604359869929,0.6177787554565155,PLB1
KEGG_2021_Human,Spinocerebellar ataxia,5/143,0.5930698716492204,0.99999603346069,0,0,0.9657966977514028,0.5045737816512197,PSMB6;PIK3CB;ATG14;PSMA7;GRIN2D
KEGG_2021_Human,alpha-Linolenic acid metabolism,1/25,0.6018996036140575,0.99999603346069,0,0,1.1110918744228993,0.5640620330878231,PLB1
KEGG_2021_Human,NOD-like receptor signaling pathway,6/181,0.642298131779534,0.99999603346069,0,0,0.9134249850567844,0.4043757102050131,GBP7;STAT1;STAT2;GBP2;GBP1;GBP3
KEGG_2021_Human,Mineral absorption,2/60,0.6435683072085954,0.99999603346069,0,0,0.919173561624181,0.4051047056300469,FTH1;FTL
KEGG_2021_Human,Viral myocarditis,2/60,0.6435683072085954,0.99999603346069,0,0,0.919173561624181,0.4051047056300469,HLA-B;HLA-A
KEGG_2021_Human,Phototransduction,1/28,0.6435837322380843,0.99999603346069,0,0,0.9874833282035498,0.4351870038148936,PDE6B
KEGG_2021_Human,Phagosome,5/152,0.6468530004637507,0.99999603346069,0,0,0.906239933299225,0.3947909317524115,TUBB6;CTSL;HLA-B;M6PR;HLA-A
KEGG_2021_Human,Th1 and Th2 cell differentiation,3/92,0.6511811972065639,0.99999603346069,0,0,0.898314606741573,0.3853476262404295,IL5;STAT1;IFNGR2
KEGG_2021_Human,Arachidonic acid metabolism,2/61,0.6525119681741627,0.99999603346069,0,0,0.9035473330355672,0.3857476661184323,PLB1;CBR3
KEGG_2021_Human,Glycerolipid metabolism,2/61,0.6525119681741627,0.99999603346069,0,0,0.9035473330355672,0.3857476661184323,AGPAT2;AGPAT4
KEGG_2021_Human,Steroid hormone biosynthesis,2/61,0.6525119681741627,0.99999603346069,0,0,0.9035473330355672,0.3857476661184323,AKR1C1;HSD17B8
KEGG_2021_Human,Linoleic acid metabolism,1/29,0.6564861964278759,0.99999603346069,0,0,0.9521666007123072,0.400722752626217,PLB1
KEGG_2021_Human,Glyoxylate and dicarboxylate metabolism,1/30,0.668922204711704,0.99999603346069,0,0,0.9192855095997708,0.3696332229564862,PGP
KEGG_2021_Human,Hepatitis C,5/157,0.6747220612918543,0.99999603346069,0,0,0.8762003371939598,0.3447449077023298,STAT1;STAT2;MX1;PIK3CB;IFIT1
KEGG_2021_Human,GnRH secretion,2/64,0.6782698359561568,0.99999603346069,0,0,0.8596930786094582,0.3337415206123811,PIK3CB;CACNA1H
KEGG_2021_Human,Asthma,1/31,0.6809085980992218,0.99999603346069,0,0,0.8885964912280702,0.3415118005347423,IL5
KEGG_2021_Human,Glycerophospholipid metabolism,3/98,0.6928120678870378,0.99999603346069,0,0,0.8413157894736842,0.3087599525546368,AGPAT2;PLB1;AGPAT4
KEGG_2021_Human,Natural killer cell mediated cytotoxicity,4/131,0.7017322714483741,0.99999603346069,0,0,0.8388728877596837,0.2971315681128376,IFNGR2;HLA-B;HLA-A;PIK3CB
KEGG_2021_Human,Progesterone-mediated oocyte maturation,3/100,0.7058280841994525,0.99999603346069,0,0,0.8238831615120275,0.2870273636130115,SPDYE1;PIK3CB;ANAPC11
KEGG_2021_Human,Fc epsilon RI signaling pathway,2/68,0.7101664168363373,0.99999603346069,0,0,0.8074223511116715,0.2763451010061635,IL5;PIK3CB
KEGG_2021_Human,Mitophagy,2/68,0.7101664168363373,0.99999603346069,0,0,0.8074223511116715,0.2763451010061635,TOMM7;RPS27A
KEGG_2021_Human,Retinol metabolism,2/68,0.7101664168363373,0.99999603346069,0,0,0.8074223511116715,0.2763451010061635,ADH4;RPE65
KEGG_2021_Human,Propanoate metabolism,1/34,0.7143295206543507,0.99999603346069,0,0,0.8076890791572232,0.271715417781688,LDHC
KEGG_2021_Human,Amphetamine addiction,2/69,0.7177154005914891,0.99999603346069,0,0,0.7953298693771089,0.2637967341720521,SLC18A2;GRIN2D
KEGG_2021_Human,Renal cell carcinoma,2/69,0.7177154005914891,0.99999603346069,0,0,0.7953298693771089,0.2637967341720521,ELOB;PIK3CB
KEGG_2021_Human,Amoebiasis,3/102,0.7184178772919833,0.99999603346069,0,0,0.8071548821548822,0.2669292492166724,ARG2;IL1R1;PIK3CB
KEGG_2021_Human,Protein digestion and absorption,3/103,0.7245541924796456,0.99999603346069,0,0,0.7990416666666667,0.2574502023744004,KCNJ13;COL10A1;SLC3A1
KEGG_2021_Human,T cell receptor signaling pathway,3/104,0.7305855707047482,0.99999603346069,0,0,0.7910891089108911,0.2483299236416832,IL5;PIK3CB;RASGRP1
KEGG_2021_Human,Mucin type O-glycan biosynthesis,1/36,0.7346444731999683,0.99999603346069,0,0,0.7614562722595963,0.2348092097600019,GCNT1
KEGG_2021_Human,Tyrosine metabolism,1/36,0.7346444731999683,0.99999603346069,0,0,0.7614562722595963,0.2348092097600019,ADH4
KEGG_2021_Human,Pathways of neurodegeneration,15/475,0.7401391593343842,0.99999603346069,0,0,0.8666635961680177,0.2607938590358249,NDUFA6;COX4I1;NDUFA2;NDUFC1;ATG14;COX7C;COX7A1;PSMA7;GRIN2D;PSMB6;TUBB6;KLC3;NDUFS5;UQCRFS1;RPS27A
KEGG_2021_Human,"Parathyroid hormone synthesis, secretion and action",3/106,0.7423361850083721,0.99999603346069,0,0,0.7756472491909385,0.2311064705224027,MMP25;NACA;PDE4A
KEGG_2021_Human,Aldosterone-regulated sodium reabsorption,1/37,0.7442543209868885,0.99999603346069,0,0,0.7402662357648507,0.2186542689405133,PIK3CB
KEGG_2021_Human,Fluid shear stress and atherosclerosis,4/139,0.7445907339607064,0.99999603346069,0,0,0.7888322258280533,0.2326428433168809,IL1R1;CTSL;GSTP1;PIK3CB
KEGG_2021_Human,Measles,4/139,0.7445907339607064,0.99999603346069,0,0,0.7888322258280533,0.2326428433168809,STAT1;STAT2;MX1;PIK3CB
KEGG_2021_Human,Th17 cell differentiation,3/107,0.7480568769636007,0.99999603346069,0,0,0.7681490384615385,0.2229754339839695,IL1R1;STAT1;IFNGR2
KEGG_2021_Human,Influenza A,5/172,0.7492836405968125,0.99999603346069,0,0,0.7968742181375411,0.230007921403544,STAT1;IFNGR2;STAT2;MX1;PIK3CB
KEGG_2021_Human,Drug metabolism,3/108,0.7536755377377509,0.99999603346069,0,0,0.7607936507936508,0.2151473660644168,ADH4;GSTP1;FMO5
KEGG_2021_Human,Pancreatic cancer,2/76,0.7660309007924184,0.99999603346069,0,0,0.7198335644937587,0.1918592335920518,STAT1;PIK3CB
KEGG_2021_Human,"Glycine, serine and threonine metabolism",1/40,0.7710482702913298,0.99999603346069,0,0,0.6832161375097663,0.1776391335797559,BHMT
KEGG_2021_Human,Nicotine addiction,1/40,0.7710482702913298,0.99999603346069,0,0,0.6832161375097663,0.1776391335797559,GRIN2D
KEGG_2021_Human,Leishmaniasis,2/77,0.7723137452001915,0.99999603346069,0,0,0.7101987979657882,0.1834900904491309,STAT1;IFNGR2
KEGG_2021_Human,Human immunodeficiency virus 1 infection,6/212,0.7825112361354989,0.99999603346069,0,0,0.7747085347524069,0.1899949420022388,BST2;HLA-B;ELOB;HLA-A;PIK3CB;B2M
KEGG_2021_Human,Retrograde endocannabinoid signaling,4/148,0.787012907034451,0.99999603346069,0,0,0.7391825065677639,0.1770420681296674,NDUFA6;NDUFS5;NDUFA2;NDUFC1
KEGG_2021_Human,Fat digestion and absorption,1/43,0.7950385241055493,0.99999603346069,0,0,0.6343160532911225,0.145489716030401,AGPAT2
KEGG_2021_Human,Fatty acid degradation,1/43,0.7950385241055493,0.99999603346069,0,0,0.6343160532911225,0.145489716030401,ADH4
KEGG_2021_Human,Porphyrin and chlorophyll metabolism,1/43,0.7950385241055493,0.99999603346069,0,0,0.6343160532911225,0.145489716030401,CP
KEGG_2021_Human,Peroxisome,2/82,0.8015617618939698,0.99999603346069,0,0,0.6656380027739252,0.1472346344999354,PRDX5;PXMP2
KEGG_2021_Human,Human T-cell leukemia virus 1 infection,6/219,0.8075873358714729,0.99999603346069,0,0,0.7489736185593336,0.1600587134966239,IL1R1;HLA-B;HLA-A;PIK3CB;B2M;ANAPC11
KEGG_2021_Human,ABC transporters,1/45,0.8096204106181342,0.99999603346069,0,0,0.6054205489801058,0.127858626506294,CFTR
KEGG_2021_Human,AMPK signaling pathway,3/120,0.8134789010646776,0.99999603346069,0,0,0.6823361823361823,0.1408582667627465,STRADB;PIK3CB;CFTR
KEGG_2021_Human,Type II diabetes mellitus,1/46,0.8165180947927516,0.99999603346069,0,0,0.5919359803016313,0.1199890964098438,PIK3CB
KEGG_2021_Human,Carbohydrate digestion and absorption,1/47,0.8231661978901863,0.99999603346069,0,0,0.579037697217873,0.1126790897607911,PIK3CB
KEGG_2021_Human,Nucleotide excision repair,1/47,0.8231661978901863,0.99999603346069,0,0,0.579037697217873,0.1126790897607911,CETN2
KEGG_2021_Human,Intestinal immune network for IgA production,1/48,0.8295737385097335,0.99999603346069,0,0,0.566688277244062,0.1058818954226609,IL5
KEGG_2021_Human,Ether lipid metabolism,1/49,0.83574940984084,0.99999603346069,0,0,0.5548534164358264,0.0995553842330838,PLB1
KEGG_2021_Human,Lysosome,3/128,0.846128746671531,0.99999603346069,0,0,0.6384,0.1066662648047087,CD63;CTSL;M6PR
KEGG_2021_Human,Proteoglycans in cancer,5/205,0.867341520343149,0.99999603346069,0,0,0.6642409470752089,0.0945364118201996,CD63;CTSL;RPS6;GPC3;PIK3CB
KEGG_2021_Human,Regulation of lipolysis in adipocytes,1/55,0.8683828603936251,0.99999603346069,0,0,0.4930491433261516,0.0695803662695532,PIK3CB
KEGG_2021_Human,Circadian entrainment,2/97,0.8702352884965086,0.99999603346069,0,0,0.5600992773195124,0.0778491268351045,CACNA1H;GRIN2D
KEGG_2021_Human,Prostate cancer,2/97,0.8702352884965086,0.99999603346069,0,0,0.5600992773195124,0.0778491268351045,GSTP1;PIK3CB
KEGG_2021_Human,Inflammatory mediator regulation of TRP channels,2/98,0.8739315960897707,0.99999603346069,0,0,0.5542360147942672,0.0746850608821883,IL1R1;PIK3CB
KEGG_2021_Human,Autophagy,3/137,0.8768203379369219,0.99999603346069,0,0,0.5952425373134328,0.0782465169115772,CTSL;PIK3CB;ATG14
KEGG_2021_Human,Glutathione metabolism,1/57,0.877752174761459,0.99999603346069,0,0,0.4753907795805303,0.0619866726188325,GSTP1
KEGG_2021_Human,AGE-RAGE signaling pathway in diabetic complications,2/100,0.8810348470823792,0.99999603346069,0,0,0.5428684650004246,0.0687586882284404,STAT1;PIK3CB
KEGG_2021_Human,Endometrial cancer,1/58,0.8821839993910364,0.99999603346069,0,0,0.4670262914904991,0.0585439073363303,PIK3CB
KEGG_2021_Human,VEGF signaling pathway,1/59,0.8864553693100757,0.99999603346069,0,0,0.4589502340242621,0.0553147472801453,PIK3CB
KEGG_2021_Human,Chagas disease,2/102,0.8877666824614828,0.99999603346069,0,0,0.5319556171983356,0.0633273562312894,IFNGR2;PIK3CB
KEGG_2021_Human,Toll-like receptor signaling pathway,2/104,0.8941439476736317,0.99999603346069,0,0,0.5214707242120149,0.0583465778953239,STAT1;PIK3CB
KEGG_2021_Human,Lysine degradation,1/63,0.9020492344435082,0.99999603346069,0,0,0.4292511839871325,0.0442498634307542,TMLHE
KEGG_2021_Human,Cell adhesion molecules,3/148,0.9068723725670964,0.99999603346069,0,0,0.5497701149425287,0.0537419818412974,HLA-B;CD99L2;HLA-A
KEGG_2021_Human,Phospholipase D signaling pathway,3/148,0.9068723725670964,0.99999603346069,0,0,0.5497701149425287,0.0537419818412974,PIK3CB;AGPAT2;AGPAT4
KEGG_2021_Human,Alcoholism,4/186,0.9078136188276344,0.99999603346069,0,0,0.5836861330602638,0.0564518972288266,H2AC20;H4C3;SLC18A2;GRIN2D
KEGG_2021_Human,Cortisol synthesis and secretion,1/65,0.9090246753685854,0.99999603346069,0,0,0.4157938019390582,0.0396596766562819,CACNA1H
KEGG_2021_Human,Spliceosome,3/150,0.9115644736337042,0.99999603346069,0,0,0.5422335600907029,0.0502070069846648,SNRPD2;SYF2;PQBP1
KEGG_2021_Human,Human cytomegalovirus infection,5/225,0.9130146420433382,0.99999603346069,0,0,0.6032223347682958,0.0548952600319749,IL1R1;HLA-B;HLA-A;PIK3CB;B2M
KEGG_2021_Human,Human papillomavirus infection,8/331,0.9147744739646964,0.99999603346069,0,0,0.6565719110610752,0.0584859292658651,STAT1;STAT2;IRF1;MX1;HLA-B;ISG15;HLA-A;PIK3CB
KEGG_2021_Human,Acute myeloid leukemia,1/67,0.915503995185358,0.99999603346069,0,0,0.4031520188029883,0.0355904823320832,PIK3CB
KEGG_2021_Human,Long-term potentiation,1/67,0.915503995185358,0.99999603346069,0,0,0.4031520188029883,0.0355904823320832,GRIN2D
KEGG_2021_Human,TNF signaling pathway,2/112,0.9164259327412018,0.99999603346069,0,0,0.483343840625394,0.0421833649958158,IRF1;PIK3CB
KEGG_2021_Human,Toxoplasmosis,2/112,0.9164259327412018,0.99999603346069,0,0,0.483343840625394,0.0421833649958158,STAT1;IFNGR2
KEGG_2021_Human,mTOR signaling pathway,3/154,0.9203101509041014,0.99999603346069,0,0,0.5277593818984547,0.0438275378466261,STRADB;RPS6;PIK3CB
KEGG_2021_Human,Leukocyte transendothelial migration,2/114,0.921264639450448,0.99999603346069,0,0,0.4746631662373687,0.0389261507114386,CD99L2;PIK3CB
KEGG_2021_Human,RIG-I-like receptor signaling pathway,1/70,0.9243691483168092,0.99999603346069,0,0,0.3855634509614998,0.0303221656551682,ISG15
KEGG_2021_Human,Cellular senescence,3/156,0.9243802416019192,0.99999603346069,0,0,0.5208061002178649,0.0409519081457004,HLA-B;HLA-A;PIK3CB
KEGG_2021_Human,Melanoma,1/72,0.9297569233063604,0.99999603346069,0,0,0.3746634934259295,0.0272875289399365,PIK3CB
KEGG_2021_Human,Non-small cell lung cancer,1/72,0.9297569233063604,0.99999603346069,0,0,0.3746634934259295,0.0272875289399365,PIK3CB
KEGG_2021_Human,"Growth hormone synthesis, secretion and action",2/119,0.93223229907754,0.99999603346069,0,0,0.4542598717355999,0.0318768903706343,STAT1;PIK3CB
KEGG_2021_Human,Neurotrophin signaling pathway,2/119,0.93223229907754,0.99999603346069,0,0,0.4542598717355999,0.0318768903706343,BEX3;PIK3CB
KEGG_2021_Human,Inositol phosphate metabolism,1/73,0.9323053117888832,0.99999603346069,0,0,0.3694405971068021,0.0258959128618489,PIK3CB
KEGG_2021_Human,Hepatitis B,3/162,0.9354742482323108,0.99999603346069,0,0,0.5009958071278826,0.033417252451357,STAT1;STAT2;PIK3CB
KEGG_2021_Human,Thyroid hormone signaling pathway,2/121,0.9362011219219468,0.99999603346069,0,0,0.446578631452581,0.0294406747259077,STAT1;PIK3CB
KEGG_2021_Human,Glioma,1/75,0.9371284267461518,0.99999603346069,0,0,0.3594182825484764,0.0233388062321001,PIK3CB
KEGG_2021_Human,Thyroid hormone synthesis,1/75,0.9371284267461518,0.99999603346069,0,0,0.3594182825484764,0.0233388062321001,DUOX1
KEGG_2021_Human,Viral carcinogenesis,4/203,0.9385370469504088,0.99999603346069,0,0,0.5333482433027446,0.0338318519667212,HLA-B;HLA-A;PIK3CB;H4C3
KEGG_2021_Human,Chronic myeloid leukemia,1/76,0.9394097145047352,0.99999603346069,0,0,0.3546075715604802,0.0221642371369828,PIK3CB
KEGG_2021_Human,Gastric acid secretion,1/76,0.9394097145047352,0.99999603346069,0,0,0.3546075715604802,0.0221642371369828,CFTR
KEGG_2021_Human,Pertussis,1/76,0.9394097145047352,0.99999603346069,0,0,0.3546075715604802,0.0221642371369828,IRF1
KEGG_2021_Human,Bacterial invasion of epithelial cells,1/77,0.9416083332109592,0.99999603346069,0,0,0.3499234582300627,0.0210534503549782,PIK3CB
KEGG_2021_Human,Platelet activation,2/124,0.9417435812767588,0.99999603346069,0,0,0.4355289784225006,0.0261414284295461,PIK3CB;RASGRP1
KEGG_2021_Human,Synaptic vesicle cycle,1/78,0.9437272745341648,0.99999603346069,0,0,0.3453610101809548,0.0200026392508988,SLC18A2
KEGG_2021_Human,RNA degradation,1/79,0.9457694220890206,0.99999603346069,0,0,0.3409155479792599,0.0190082507632488,ENO4
KEGG_2021_Human,Salmonella infection,5/249,0.9491433312867026,0.99999603346069,0,0,0.543204027581168,0.0283527828738954,TUBB6;KLC3;M6PR;DYNLRB1;PIK3CB
KEGG_2021_Human,Protein processing in endoplasmic reticulum,3/171,0.949326070845106,0.99999603346069,0,0,0.4739335317460317,0.0246459394990628,SELENOS;SEL1L2;SVIP
KEGG_2021_Human,B cell receptor signaling pathway,1/81,0.9496343531582996,0.99999603346069,0,0,0.3323580332409972,0.0171756848182172,PIK3CB
KEGG_2021_Human,Oocyte meiosis,2/129,0.9499773844140504,0.99999603346069,0,0,0.4182729585986218,0.021464555474112,SPDYE1;ANAPC11
KEGG_2021_Human,cAMP signaling pathway,4/216,0.955397544874081,0.99999603346069,0,0,0.5003017818248616,0.0228276435078494,PDE4A;PIK3CB;CFTR;GRIN2D
KEGG_2021_Human,Complement and coagulation cascades,1/85,0.956558452378144,0.99999603346069,0,0,0.316465505869938,0.0140553031728117,F8
KEGG_2021_Human,ErbB signaling pathway,1/85,0.956558452378144,0.99999603346069,0,0,0.316465505869938,0.0140553031728117,PIK3CB
KEGG_2021_Human,Colorectal cancer,1/86,0.9581354877055268,0.99999603346069,0,0,0.3127260876649829,0.0133740699288178,PIK3CB
KEGG_2021_Human,Systemic lupus erythematosus,2/135,0.9583957084381663,0.99999603346069,0,0,0.3992783623413596,0.0169671461356292,H2AC20;H4C3
KEGG_2021_Human,Insulin signaling pathway,2/137,0.9608870534511602,0.99999603346069,0,0,0.3933220321569836,0.0156929225787997,RPS6;PIK3CB
KEGG_2021_Human,Gap junction,1/88,0.9611200967922404,0.99999603346069,0,0,0.3055051421657592,0.0121150835584568,TUBB6
KEGG_2021_Human,Bile secretion,1/90,0.9638921872536328,0.99999603346069,0,0,0.2986087335429052,0.010981583894245,CFTR
KEGG_2021_Human,Morphine addiction,1/91,0.9652033035356816,0.99999603346069,0,0,0.2952754693751924,0.0104576303324138,PDE4A
KEGG_2021_Human,RNA transport,3/186,0.966426718893808,0.99999603346069,0,0,0.4347449908925319,0.0148464563688676,POP5;EIF2S2;RPP38
KEGG_2021_Human,Small cell lung cancer,1/92,0.9664668717827712,0.99999603346069,0,0,0.2920154637606161,0.00996013860287,PIK3CB
KEGG_2021_Human,Apoptosis,2/142,0.9665048099036244,0.99999603346069,0,0,0.3791757479690905,0.0129181399702641,CTSL;PIK3CB
KEGG_2021_Human,Rheumatoid arthritis,1/93,0.9676846140446396,0.99999603346069,0,0,0.2888263278333132,0.0094876724284481,CTSL
KEGG_2021_Human,IL-17 signaling pathway,1/94,0.9688581899629938,0.99999603346069,0,0,0.2857057754743395,0.0090388806437646,IL5
KEGG_2021_Human,TGF-beta signaling pathway,1/94,0.9688581899629938,0.99999603346069,0,0,0.2857057754743395,0.0090388806437646,THSD4
KEGG_2021_Human,Neutrophil extracellular trap formation,3/189,0.9691184156954872,0.99999603346069,0,0,0.427665770609319,0.0134152211252827,H2AC20;PIK3CB;H4C3
KEGG_2021_Human,Chemokine signaling pathway,3/192,0.9716052974456876,0.99999603346069,0,0,0.4208112874779541,0.0121217340694316,STAT1;STAT2;PIK3CB
KEGG_2021_Human,Fc gamma R-mediated phagocytosis,1/97,0.9721296302376063,0.99999603346069,0,0,0.2767341874422899,0.0078222014658532,PIK3CB
KEGG_2021_Human,Phosphatidylinositol signaling system,1/97,0.9721296302376063,0.99999603346069,0,0,0.2767341874422899,0.0078222014658532,PIK3CB
KEGG_2021_Human,Aldosterone synthesis and secretion,1/98,0.9731419699901404,0.99999603346069,0,0,0.2738669788959648,0.0074561100832137,CACNA1H
KEGG_2021_Human,Choline metabolism in cancer,1/98,0.9731419699901404,0.99999603346069,0,0,0.2738669788959648,0.0074561100832137,PIK3CB
KEGG_2021_Human,mRNA surveillance pathway,1/98,0.9731419699901404,0.99999603346069,0,0,0.2738669788959648,0.0074561100832137,FIP1L1
KEGG_2021_Human,Viral protein interaction with cytokine and cytokine receptor,1/100,0.9750578026877126,0.99999603346069,0,0,0.2683063320182434,0.0067770221771401,ACKR4
KEGG_2021_Human,Melanogenesis,1/101,0.9759639085027008,0.99999603346069,0,0,0.2656094182825484,0.0064621900922435,ASIP
KEGG_2021_Human,Longevity regulating pathway,1/102,0.976837137562539,0.99999603346069,0,0,0.2629659087792436,0.0061626947681971,PIK3CB
KEGG_2021_Human,Pancreatic secretion,1/102,0.976837137562539,0.99999603346069,0,0,0.2629659087792436,0.0061626947681971,CFTR
KEGG_2021_Human,NF-kappa B signaling pathway,1/104,0.9784896872887278,0.99999603346069,0,0,0.2578328806174865,0.0056065841128008,IL1R1
KEGG_2021_Human,Shigellosis,4/246,0.9793563932092576,0.99999603346069,0,0,0.4375912366808814,0.0091280064684334,IL1R1;PIK3CB;ATG14;RPS27A
KEGG_2021_Human,Glucagon signaling pathway,1/107,0.980750349130216,0.99999603346069,0,0,0.2504965243296921,0.0048689855885896,LDHC
KEGG_2021_Human,Insulin resistance,1/108,0.9814498788384668,0.99999603346069,0,0,0.2481424910037021,0.0046463024964864,PIK3CB
KEGG_2021_Human,Cytokine-cytokine receptor interaction,5/295,0.9831615283285736,0.99999603346069,0,0,0.4559360291998847,0.0077426375014663,IL5;IL1R1;IL7;IFNGR2;ACKR4
KEGG_2021_Human,Cholinergic synapse,1/113,0.9845845847116126,0.99999603346069,0,0,0.2370028690146418,0.0036819505295529,PIK3CB
KEGG_2021_Human,Serotonergic synapse,1/113,0.9845845847116126,0.99999603346069,0,0,0.2370028690146418,0.0036819505295529,SLC18A2
KEGG_2021_Human,Glutamatergic synapse,1/114,0.985144928177505,0.99999603346069,0,0,0.2348932414875101,0.003515532852818,GRIN2D
KEGG_2021_Human,Hepatocellular carcinoma,2/168,0.9852491339148772,0.99999603346069,0,0,0.319352305198603,0.0047458122014204,GSTP1;PIK3CB
KEGG_2021_Human,Herpes simplex virus 1 infection,10/498,0.9868362427666252,0.99999603346069,0,0,0.5400006897661692,0.0071556395528496,BST2;ZFP69;STAT1;IFNGR2;STAT2;HLA-B;ZNF77;PIK3CB;HLA-A;B2M
KEGG_2021_Human,Sphingolipid signaling pathway,1/119,0.9876558339047536,0.99999603346069,0,0,0.2248814498333255,0.0027932498282947,PIK3CB
KEGG_2021_Human,Cell cycle,1/124,0.989742736647487,0.99999603346069,0,0,0.2156836249802941,0.002223748124949,ANAPC11
KEGG_2021_Human,Tuberculosis,2/180,0.9899652245573564,0.99999603346069,0,0,0.2976359301220215,0.0030017962143501,STAT1;IFNGR2
KEGG_2021_Human,Relaxin signaling pathway,1/129,0.9914771525769528,0.99999603346069,0,0,0.2072043801939058,0.0017735399044494,PIK3CB
KEGG_2021_Human,FoxO signaling pathway,1/131,0.992085899483968,0.99999603346069,0,0,0.2039953121670573,0.0016208617302133,PIK3CB
KEGG_2021_Human,Dopaminergic synapse,1/132,0.9923737846259838,0.99999603346069,0,0,0.2024275232073756,0.0015496724971349,SLC18A2
KEGG_2021_Human,Calcium signaling pathway,3/240,0.992920202115934,0.99999603346069,0,0,0.3347398030942334,0.0023783191284978,MST1;CACNA1H;GRIN2D
KEGG_2021_Human,Apelin signaling pathway,1/137,0.9936636708637828,0.99999603346069,0,0,0.1949344142088968,0.0012390984350694,RPS6
KEGG_2021_Human,Estrogen signaling pathway,1/137,0.9936636708637828,0.99999603346069,0,0,0.1949344142088968,0.0012390984350694,PIK3CB
KEGG_2021_Human,Yersinia infection,1/137,0.9936636708637828,0.99999603346069,0,0,0.1949344142088968,0.0012390984350694,PIK3CB
KEGG_2021_Human,Pathogenic Escherichia coli infection,2/197,0.9942210602466646,0.99999603346069,0,0,0.271446352999751,0.0015732222896575,TUBB6;IL1R1
KEGG_2021_Human,Signaling pathways regulating pluripotency of stem cells,1/143,0.994927127092351,0.99999603346069,0,0,0.1866392259373415,0.0009492067160355808,PIK3CB
KEGG_2021_Human,Endocytosis,3/252,0.9950539583398326,0.99999603346069,0,0,0.3184069611780455,0.0015787616317396,HLA-B;HLA-A;EPN1
KEGG_2021_Human,Breast cancer,1/147,0.9956262393752616,0.99999603346069,0,0,0.1814878761431336,0.0007955255165993577,PIK3CB
KEGG_2021_Human,Gastric cancer,1/149,0.9959388137284676,0.99999603346069,0,0,0.1790166204986149,0.0007285001322283846,PIK3CB
KEGG_2021_Human,Cushing syndrome,1/155,0.996748844195604,0.99999603346069,0,0,0.1719879843148541,0.0005600706661232849,CACNA1H
KEGG_2021_Human,Pathways in cancer,9/531,0.997247900764142,0.99999603346069,0,0,0.4528880517724331,0.0012481111128893,IL5;STAT1;IL7;IFNGR2;GSTP1;STAT2;ELOB;PIK3CB;RASGRP1
KEGG_2021_Human,Wnt signaling pathway,1/166,0.9978378391061068,0.99999603346069,0,0,0.1604297825904474,0.0003472505433331742,SFRP2
KEGG_2021_Human,cGMP-PKG signaling pathway,1/167,0.997916550517872,0.99999603346069,0,0,0.1594549944932083,0.00033256298521281704,PDE5A
KEGG_2021_Human,Tight junction,1/169,0.9980654805659296,0.99999603346069,0,0,0.1575402321593457,0.000305059808053095,CFTR
KEGG_2021_Human,Ras signaling pathway,2/232,0.9981783874843968,0.99999603346069,0,0,0.229717180244829,0.00041883728612788086,PIK3CB;RASGRP1
KEGG_2021_Human,Chemical carcinogenesis,2/239,0.998557469380391,0.99999603346069,0,0,0.2228503543484494,0.00032170054700873395,GSTP1;PIK3CB
KEGG_2021_Human,MAPK signaling pathway,3/294,0.9986290355420142,0.99999603346069,0,0,0.2718499427262313,0.0003729523200258632,IL1R1;RASGRP1;CACNA1H
KEGG_2021_Human,Axon guidance,1/182,0.9988053645320142,0.99999603346069,0,0,0.1461257097381429,0.0001746713106952721,PIK3CB
KEGG_2021_Human,Focal adhesion,1/201,0.9994090379455166,0.99999603346069,0,0,0.1321121883656509,7.809636852756958e-05,PIK3CB
KEGG_2021_Human,Rap1 signaling pathway,1/210,0.9995763266503574,0.99999603346069,0,0,0.126363503823775,5.354819320993774e-05,PIK3CB
KEGG_2021_Human,Lipid and atherosclerosis,1/215,0.9996477408361306,0.99999603346069,0,0,0.1233787247262277,4.3468943027666153e-05,PIK3CB
KEGG_2021_Human,Regulation of actin cytoskeleton,1/218,0.9996846331006516,0.99999603346069,0,0,0.1216538800311474,3.837165783257887e-05,PIK3CB
KEGG_2021_Human,Neuroactive ligand-receptor interaction,3/341,0.9996856748807108,0.99999603346069,0,0,0.2334689349112426,7.339668663180801e-05,P2RY10;UTS2;GRIN2D
KEGG_2021_Human,PI3K-Akt signaling pathway,3/354,0.999791526105672,0.99999603346069,0,0,0.224667616334283,4.68422157658588e-05,IL7;RPS6;PIK3CB
KEGG_2021_Human,MicroRNAs in cancer,2/310,0.9998673600894912,0.99999603346069,0,0,0.1708395626564836,2.2661647254762457e-05,PIK3CB;BCL2L2
KEGG_2021_Human,Olfactory transduction,1/440,0.99999603346069,0.99999603346069,0,0,0.0594337420099823,2.357467415665061e-07,ANO2
